This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users. (DIUQoL)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: September 17, 2012
Last updated: July 15, 2015
Last verified: July 2015
Knowledge about the impact on quality of life of women initiating IUD in the Spanish population at baseline and after 12 months of use.

Condition Intervention
Contraception Drug: Levonorgestrel IUD or Copper IUD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.

Resource links provided by NLM:

Further study details as provided by Bayer:

Primary Outcome Measures:
  • Impact on quality of life of women initiating IUD in a Spanish population assessed by questionnaire. [ Time Frame: After 12 months ]

Secondary Outcome Measures:
  • Demographic Data (Age, Place of Birth, Level of Education, Employment status, Personal marital situation, etc.) assessed by questionnaire. [ Time Frame: Baseline ]

Enrollment: 207
Study Start Date: July 2012
Study Completion Date: July 2014
Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Group 1 Drug: Levonorgestrel IUD or Copper IUD
Women who initiate the use of an IUD at the time of the study.


Ages Eligible for Study:   18 Years to 49 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women who starts contraception with an IUD.

Inclusion Criteria:

  • 18-49 years old female.
  • Women who is visited by a gynecology or primary care physician and starts contraception with an IUD/IUS.
  • Women that has not used hormonal contraception in any form in the last 3 months.
  • Women who have no problems listening, reading or writing.
  • Women who gives their written consent to participate in the study.

Exclusion Criteria:

  • Women who have contraindications to use IUDs.
  • Women with previous experience with IUDs.
  • Women who initiates the use of IUDs for other purposes other than contraception.
  • Woman who is participating in a clinical trial at the time of initiating the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01731132

Many Locations, Spain
Sponsors and Collaborators
Study Director: Bayer Study Director Bayer
  More Information

Additional Information:
Responsible Party: Bayer Identifier: NCT01731132     History of Changes
Other Study ID Numbers: 16341
MA1213ES ( Other Identifier: Company Internal )
BAY-DIU-2011-01 ( Other Identifier: Company Internal )
Study First Received: September 17, 2012
Last Updated: July 15, 2015

Keywords provided by Bayer:

Additional relevant MeSH terms:
Contraceptive Agents, Female
Contraceptive Agents
Reproductive Control Agents
Physiological Effects of Drugs
Contraceptives, Oral, Synthetic
Contraceptives, Oral processed this record on September 21, 2017